284 related articles for article (PubMed ID: 20055881)
1. Desmoglein1 and BP 180 ELISA indexes correlating with disease activity in a patient with coexisting pemphigus foliaceus and bullous pemphigoid.
Ando S; Sato-Matsumura KC; Kasai M; Nemoto-Hasebe I; Hoshina D; Ohyama B; Hashimoto T; Shimuzu H
Clin Exp Dermatol; 2009 Dec; 34(8):e995-6. PubMed ID: 20055881
[No Abstract] [Full Text] [Related]
2. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
Andreadis D; Lorenzini G; Drakoulakos D; Belazi M; Mihailidou E; Velkos G; Mourellou-Tsatsou O; Antoniades D
Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
[TBL] [Abstract][Full Text] [Related]
3. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
4. [Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].
Amagai M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():614-7. PubMed ID: 20942145
[No Abstract] [Full Text] [Related]
5. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of paraneoplastic pemphigus and bullous pemphigoid.
Kakurai M; Demitsu T; Iida E; Umemoto N; Yamada T; Yoneda K; Kako S; Ohshima K; Ohyama B; Hashimoto T
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):962-4. PubMed ID: 19207671
[No Abstract] [Full Text] [Related]
9. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
10. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J
J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
12. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
[No Abstract] [Full Text] [Related]
13. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
[No Abstract] [Full Text] [Related]
14. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
Korman NJ; Stanley JR; Woodley DT
Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320
[TBL] [Abstract][Full Text] [Related]
16. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
Julio T; Vernal S; Turatti A; Roselino AM
Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
[No Abstract] [Full Text] [Related]
17. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
[No Abstract] [Full Text] [Related]
18. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic bullous pemphigoid: clinical disease activity correlated with enzyme-linked immunosorbent assay index for the NC16A domain of BP180.
Song HJ; Han SH; Hong WK; Lee HS; Shin JH; Choi GS
J Dermatol; 2009 Jan; 36(1):66-8. PubMed ID: 19207441
[No Abstract] [Full Text] [Related]
20. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects.
Wieland CN; Comfere NI; Gibson LE; Weaver AL; Krause PK; Murray JA
Arch Dermatol; 2010 Jan; 146(1):21-5. PubMed ID: 20083688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]